Chemyo Review: Are Their SARMs Actually Worth It?
The SARMs market is, to put it bluntly, a mess. A 2017 study published in JAMA found that 48% of products sold as SARMs were mislabeled, underdosed, or contained no active compound whatsoever. That’s not a niche problem. That’s the norm. Against that backdrop, Chemyo has spent nearly a decade building a reputation that most…